5 Best Quality Stocks To Watch For 2014

When traders think of an IP (intellectual property) company, they tend to conjure up names like InterDigital, Inc. (NASDAQ:IDCC), VirnetX Holding Corporation (NYSEMKT:VHC), or of course, the well-known Vringo, Inc. (NASDAQ:VRNG). And, investors see these patent-enforcement names as such for good reason.... between VRNG, IDCC, and VHC, the three organizations own well over 20,000 technology patents, and their efforts to enforce them have been well-documented, and well publicized. Thing is, as the patent-protection industry matures, companies like Vringo, InterDigital, or VirnetX Holding may well find that it's the quality of the patent portfolio rather than the quantity of patents that makes an IP owner a potent investment. Enter Endeavor IP Inc. (OTCBB:ENIP).

Most traders won't have heard of Endeavor IP. That may be because its market cap is a mere $30.5 million, and it hasn't actually posted any quarterly revenue yet. Oh yeah... something else about ENIP - its patent portfolio only consists of three patents, only two of which have actually been issued. The third one is only "allowed" at this point (though Endeavor IP Inc. does believe it will be issued by the USPTO in the foreseeable future).

Best Medical Companies To Invest In Right Now: Spherix Inc (SPEX)

Spherix Incorporated (Spherix), incorporated on May 1, 1992, is a scientific research company. The Company is engaged in developing biopharmaceutical products and providing technical and regulatory consulting services to food, consumer products and pharmaceutical companies. The Company operates in two segments: Biospherics Incorporated (Biospherics), the Company's biotechnology research and development business, and Health Sciences, a technical and regulatory consulting business. The Company has created two wholly owned subsidiaries, Biospherics Incorporated and Spherix Consulting, Inc. (Spherix Consulting), for its two operating segments. The Company's Health Sciences contracts are in the name of Spherix Consulting, and the Company's patents are in the name of Biospherics Incorporated. Spherix provides management, strategic guidance, business development, marketing and other services to its subsidiaries. In September 2013, Spherix Incorporated closed on the acquisition of North South Holdings Inc.

Biospherics

The Company focuses its studies on treating high triglycerides and other dyslipidemias with a combination of D-tagatose and SPX-106, a licensed drug compound, which combination is referred to as SPX-106T. Spherix Consulting provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides. Biospherics has also completed a global Phase III clinical trial investigating the use of D-Tagatose, a stereoisomer of fructose, as a treatment for glycemic control in patients with Type 2 diabetes.

Health Sciences

The Company's Health Sciences business provides technical and regulatory consulting services to biotechnology and pharmaceutical companies, as well as providing technical suppo! rt for its research and development activities. During the year ended December 31, 2011, Health Sciences provided services to 20 companies. The projects range from safety analyses of food ingredients to safety analyses of pharmaceutical manufacturing and dispensing equipment. Health Sciences is also monitoring and directing the clinical trials for Biospherics.

Advisors' Opinion:

• [By Susan Decker]

  In more than two decades as a publicly-traded company, Spherix Inc. (SPEX) developed diabetes treatments, marketed a low-calorie sweetener and handled campground reservations. Now it�� dealing in something completely different: patents.

5 Best Quality Stocks To Watch For 2014: Tandem Diabetes Care Inc (TNDM)

Tandem Diabetes Care, Inc., incorporated on July 1, 2008, is a medical device company with an approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The Company designed and commercialized its flagship product, the t:slim Insulin Delivery System, or t:slim, based on its technology platform and consumer-focused approach. Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump�� cartridge rather than relying on a syringe and plunger mechanism. The Company also applies the science of human factors to its design and development process, which seeks to optimize its devices to the intended users, allowing users to successfully operate the devices in their intended environment.

The Company developed t:slim to offer the specific features that people with insulin-dependent diabetes seek in a next-generation insulin pump. The Company designed it to have the look and feel of a modern consumer electronic device, such as a smartphone. It is the insulin pump to feature a high resolution, color touchscreen. It is also the slimmest and smallest durable insulin pump on the market, and can easily and discreetly fit into a pocket, while still carrying a cartridge with 300 units of insulin.

The Company designed its flagship product, t:slim, to have the look and feel of a modern consumer electronic device, such as a smartphone. t:slim is the slimmest and smallest durable insulin pump on the market. With its narrow profile, which is similar to many smartphones, t:slim can easily and discreetly fit into a pocket. Its technology platform allows for the use of a vivid touchscreen and easy-to-navigate software architecture, which provide users simple access to the key functions of t:slim directly from the Home Screen. Insulin pump users can quickly learn how to efficiently navigate t:slim�� software, thereby enabling healthcare providers to spend! less time teaching a person how to use the pump and more time improving management of their diabetes. Its software also features numerous shortcuts, including a simple way to return to the Home Screen and view critical information for therapy management. Its technology is specifically designed to help prevent the unintentional delivery of insulin and reduce fear associated with using a pump.

Advisors' Opinion:

• [By Paul Ausick]

  Insulin pump maker Tandem Diabetes Care Inc. (NASDAQ: TNDM) sold 8 million shares on Thursday at an IPO price of $15. The stock began trading at around $19 before closing about flat to the opening bid and then shooting up more than 13% on Friday to close at $21.84.

5 Best Quality Stocks To Watch For 2014: Globe International Ltd (GLB)

Globe International Limited is an Australia-based company, engaged in the design, marketing and distribution of apparel, footwear and skate hardgoods brands for the action sports and street fashion markets. The company operates in the sale of goods in the Action Sports market. The Company operates in three segments include Australasia, North America and Europe. Globe International products were sold to nearly 100 countries around the world.The Company maintains distribution business of third party owned brands for the Australian and New Zealand market operating under its Hardcore and 4 Front divisions. As of June 30, 2012, the Company�� proprietary brands include Globe, Enjoi, Blind, Dusters, Almost, Cliche, Darkstar, Speed Demons, Tensor and Gallaz. Advisors' Opinion:

• [By Inyoung Hwang]

  Glanbia Plc (GLB) rallied the most in more than two years as food and beverage shares gained. Hennes & Mauritz AB jumped 6.9 percent after reporting monthly sales that beat estimates. Edenred SA rose 7.8 percent after Raymond James Financial Inc. said margins may improve in 2014. Fresnillo Plc sank 14 percent after missing out on inclusion in a gold-miners gauge.

5 Best Quality Stocks To Watch For 2014: The Ultimate Software Group Inc.(ULTI)

The Ultimate Software Group, Inc., together with its subsidiaries, designs, develops, and markets unified human capital management software-as-a-service solutions to businesses in the United States and Canada. Its UltiPro software solution offers businesses with cloud-based functionality to manage the employment life cycle from recruitment to retirement. The UltiPro solution includes feature sets for talent acquisition and onboarding, human resource management and compliance, benefits management and online enrollment, payroll, performance management, salary planning and budgeting for compensation management, succession management, reporting and analytical decision-making tools, and time and attendance, as well as role-based access for executives, managers, administrators, and employees. The company offers its products and services for various industries, including manufacturing, food services, sports, technology, finance, insurance, retail, real estate, transportation, com munications, healthcare, and other services. It also provides implementation, training, maintenance, and technical support services. The Ultimate Software Group, Inc. markets its products under the UltiPro Enterprise and UltiPro Workplace brand names through its direct sales teams. The company was founded in 1990 and is headquartered in Weston, Florida.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Ultimate Software Group (Nasdaq: ULTI  ) , whose recent revenue and earnings are plotted below.

• [By Alexandra Scaggs]

  Then the bank appeared to backpedal a bit in its note yesterday, cutting back on its recommended holdings in Ultimate Software Group(ULTI) and Mastercard(MA) and adding to its recommended positions in Anadarko Petroleum Corp.(APC), an energy stock, and Philip Morris International Inc.(PM), a consumer-staples stock. Morgan Stanley strategist Adam Parker �and his�team found that times when value stocks outperform growth stocks by such a wide margin “are typically followed by periods where value outperforms.”

• [By Patricio Kehoe]

  The firm is currently Zacks Rank # 3 - Hold, and it also has a longer-term recommendation of ��utperfom�� For investors looking for a Zacks Rank # 1 ��Strong Buy, Dealertrack Technologies Inc (TRAK), Open Text Corporation (OTEX), Pegasystems Inc. (PEGA) Solera Holdings (SLH) or Ultimate Software Group Inc. (ULTI) could be the options.

• [By MONEYMORNING.COM]

  Jeff Bezos at Amazon.com Inc. (Nasdaq: AMZN), Steve Singh of Concur Technologies Inc. (Nasdaq: CNQR), and Scott Scherr at Ultimate Software Group Inc. (Nasdaq: ULTI) are all tied at 18 years. And Reed Hastings of Netflix Inc. (Nasdaq: NFLX) is right behind them with a 16-year stint.